Clinical Study

Efficacy and Safety of the Traditional Japanese Medicine Keigairengyoto in the Treatment of Acne Vulgaris

Table 2

Safety assessment.

ā€‰ Control groupKRT group
Patient #1Patient #1Patient #2Patient #3Patient #4

Adverse eventDry skinErythema
on right cheek
ColdXerotic eczemaExacerbated
rash

SeverityNot seriousNot seriousNot seriousNot seriousNot serious

Speculated drugAdapaleneAdapalene-AdapaleneKeigairengyoto

OutcomeImprovedImprovedRecoveredRecoveredRecovered

Observation time1 week1 week3 weeks
+ 5 days
3 weeks
+ 1 day
4 days

Belonging to PPSYesYesYesYesNo

Patients were randomized into the conventional treatment group (control group) or the conventional treatment group with Keigairengyoto (KRT group), and they were treated for 12 weeks. Adverse events of local and systemic symptoms were collected throughout the study period.
Observation time shows the duration from the start of treatment in the present study to finding an adverse event. PPS, per protocol set.